FDA Approves Erivedge Capsule, the First Medicine for Adults with Advanced Basal Cell Carcinoma

Genentech Press Release (01/30/12)
Genentech has announced that Erivedge (vismodegib) capsule was approved by the FDA for the treatment of adults with basal cell carcinoma that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation. Erivedge is the first FDA-approved medicine for people with advanced forms of the most common skin cancer. It is a capsule that is taken orally once-a-day.

Read the complete article


Share |

Sponsor Highlights